Constipation is a common clinical problem with a multifactorial etiology, often causing significant discomfort and negatively impacting the quality of life. Despite its frequency, it remains underdiagnosed and undertreated in clinical practice. This article aims to provide a comprehensive approach to diagnosing and treating constipation.
Diagnosis begins with a thorough history and physical examination, focusing on diet, lifestyle, medication use, and psychosocial factors. It is crucial to differentiate between chronic functional constipation and secondary constipation. Where necessary, diagnostic tests such as anorectal manometry, colonic transit studies, and defecography can be employed to identify underlying pathophysiology.
Management strategies should be individualized, considering the patient's preferences, lifestyle, and underlying causes. Initial treatment typically involves lifestyle modifications, including increased dietary fiber, fluid intake, and physical activity. Pharmacological therapies, such as laxatives, are used as second-line treatment. For patients who do not respond to these measures, more advanced treatments such as biofeedback therapy or surgery may be considered.
Emerging evidence suggests a role for gut microbiota in the pathogenesis of constipation. Probiotics, particularly Bifidobacterium and Lactobacillus species, have shown promise in improving bowel frequency and consistency. However, more robust clinical trials are needed to confirm these findings and to establish optimal dosing and duration of therapy.
Constipation is a prevalent condition that requires a comprehensive, individualized approach to diagnosis and management. Clinicians should be vigilant in identifying secondary causes and promptly initiating appropriate treatment. Emerging therapies such as probiotics represent exciting new avenues for treatment. However, further research is needed to fully elucidate their role in managing constipation.
1.
FDA Declines to Approve Achieve Life Sciences' Smoking-cessation Drug
2.
Uncovered biology underlies a novel drug used to treat triple-negative breast cancer.
3.
Chemotherapy damage to non-cancer cells may be the cause of breast cancer recurrence.
4.
Never in a million years did I think I'd have to limit my chemotherapy.
5.
Treating Depression: Crucial for Recovery From Fibromyalgia
1.
HCC in Melanoma: Role of HCC Codes and Moderate Whole Body Hyperthermia
2.
Clinical Analysis of Prostate Cancer
3.
Sorafenib: Understanding the science behind a powerful cancer drug
4.
Early-Onset GI Cancers: Screening, AI Innovations & Research Advances 2025
5.
Comprehensive Breakthroughs in Oncology for Better Care
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
Asian Symposium on Advancement in Hematology and Oncology
4.
International Cancer Conference
5.
Asian Symposium on Advancement in Hematology and Oncology
1.
Understanding the Evolution in Lung Cancer- An Initiative from Manipal Hospitals: Further Discussion
2.
Experts' Opinion on the Goal of Treatment of Patients with Relapsed Adult B-cell ALL
3.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
4.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
5.
Treatment Sequencing Strategies in ALK + NSCLC Patients with CNS Diseases
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation